Search results
For example, if the 5-year relative survival rate for a specific stage of nasal cavity (nose) or paranasal sinus cancer is 80%, it means that people who have that cancer are, on average, about 80% as likely as people who don’t have that cancer to live for at least 5 years after being diagnosed.
27 cze 2024 · Except surgery and other primary treatments for sinonasal tumors, salvage treatment was performed in 70% of 62 total cases and was effective in 60% of cases (Table 2). Overall survivals after 5 and 10 years were 70% and 49%, respectively (Table 1).
2 cze 2022 · Conclusions: On average, we found a man undergoing radical prostatectomy for localized prostate cancer can expect about a 1 in 4 chance of biochemical recurrence. Of men with BCR, we identified a 1 in 10 chance of developing metastases, surviving nearly 9 years after incident metastasis.
6 cze 2022 · The five-year survival rate for localized nasal cavity and paranasal sinus cancer is about 86 percent. Regional — The cancer has spread from the sinus area to nearby lymph nodes or structures. The five-year survival rate for regional nasal cavity and paranasal sinus cancer is about 52 percent.
25 cze 2021 · Results. The 5-year outcomes were as follows: local control (LC), 80%; neck control, 96%; local-regional control, 78%; freedom from distant metastases, 71%; and disease-free survival, 62%; cause-specific survival, 64%; and overall survival, 59%.
17 maj 2021 · Results. We analyzed 10,535 patients. Diagnosis after the year 2000 was independently associated with improved DSS (HR:0.81, 95% CI: 0.75-0.87, P < .001) after controlling for age and stage.
5 lip 2024 · Paranasal sinus and nasal cavity cancer treatment often is a combination of surgery and radiation therapy for operable tumors. Chemotherapy may be used as palliation in recurrent disease. Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.
